home / stock / ibrx / ibrx quote
Last: | $6.28 |
---|---|
Change Percent: | 0.0% |
Open: | $6.18 |
Close: | $6.28 |
High: | $6.345 |
Low: | $6.17 |
Volume: | 766,530 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.28 | $6.18 | $6.28 | $6.345 | $6.17 | 766,530 | 07-03-2024 |
$6.18 | $6.28 | $6.18 | $6.28 | $6.01 | 1,669,051 | 07-02-2024 |
$6.27 | $6.38 | $6.27 | $6.65 | $6.24 | 2,226,852 | 07-01-2024 |
$6.32 | $6.5 | $6.32 | $6.555 | $6.2 | 5,920,816 | 06-28-2024 |
$6.54 | $6.67 | $6.54 | $6.74 | $6.31 | 2,771,541 | 06-27-2024 |
$6.77 | $7.27 | $6.77 | $7.27 | $6.74 | 3,089,414 | 06-26-2024 |
$7.27 | $7.23 | $7.27 | $7.36 | $6.99 | 3,556,114 | 06-25-2024 |
$7.34 | $7.5 | $7.34 | $7.63 | $7.17 | 4,934,255 | 06-24-2024 |
$7.26 | $6.7 | $7.26 | $7.349 | $6.5 | 14,973,401 | 06-21-2024 |
$6.5 | $6.43 | $6.5 | $7.37 | $6.33 | 6,298,734 | 06-20-2024 |
$6.23 | $5.84 | $6.23 | $6.35 | $5.8 | 2,663,726 | 06-19-2024 |
$6.23 | $5.84 | $6.23 | $6.35 | $5.8 | 2,663,726 | 06-18-2024 |
$5.83 | $5.91 | $5.83 | $6.2 | $5.79 | 3,684,893 | 06-17-2024 |
$5.96 | $5.92 | $5.96 | $6.05 | $5.66 | 2,686,223 | 06-14-2024 |
$5.87 | $5.63 | $5.87 | $5.915 | $5.53 | 2,659,455 | 06-13-2024 |
$5.6 | $6.14 | $5.6 | $6.155 | $5.49 | 5,203,364 | 06-12-2024 |
$5.96 | $6.12 | $5.96 | $6.675 | $5.9 | 4,790,981 | 06-11-2024 |
$6.24 | $6.05 | $6.24 | $6.265 | $5.93 | 3,096,818 | 06-10-2024 |
$6.1 | $6 | $6.1 | $6.36 | $5.9057 | 2,496,286 | 06-07-2024 |
$6.09 | $6.21 | $6.09 | $6.31 | $6.03 | 2,265,073 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Multiple patients treated across the U.S. with ANKTIVA less than eight weeks after FDA approval of first-in-class cytokine immunotherapy for BCG unresponsive non-muscle invasive bladder cancer ANKTIVA launch initiates the next era of immunotherapy beyond checkpoint inhibitors that is based on...
2024-06-07 10:10:00 ET June 7, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of viruses, featuring Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical the...
ImmunityBio, Inc. ( NASDAQ: IBRX ) announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time. The Annual Meeting will be held in a virtual-only format and there will not be a physical location for the Annual Meeting. Stockhol...